Healthcare provider profile · identity verified

Bhavjot Kaur

Internal Medicine · EDINA, MN · NPI 1609850262

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	186
Amlodipine Besylate	Amlodipine Besylate	437	143
Levothyroxine Sodium	Levothyroxine Sodium	389	108
Losartan Potassium	Losartan Potassium	357	109
Lisinopril	Lisinopril	350	93
Rosuvastatin Calcium	Rosuvastatin Calcium	315	91
Omeprazole	Omeprazole	258	74
Metoprolol Succinate	Metoprolol Succinate	253	74
Hydrochlorothiazide	Hydrochlorothiazide	205	58
Gabapentin	Gabapentin	158	52
Alendronate Sodium	Alendronate Sodium	147	53
Simvastatin	Simvastatin	124	41
Metformin Hcl Er	Metformin Hcl	119	37
Pantoprazole Sodium	Pantoprazole Sodium	112	37
Ezetimibe	Ezetimibe	107	34
Eliquis	Apixaban	100	29
Furosemide	Furosemide	98	35
Escitalopram Oxalate	Escitalopram Oxalate	91	31
Sertraline Hcl	Sertraline Hcl	84	28
Fluticasone Propionate	Fluticasone Propionate	82	35
Tamsulosin Hcl	Tamsulosin Hcl	82	26
Carvedilol	Carvedilol	81	26
Pravastatin Sodium	Pravastatin Sodium	76	22
Atenolol	Atenolol	71	20
Metoprolol Tartrate	Metoprolol Tartrate	71	18
Trazodone Hcl	Trazodone Hcl	71	25
Ozempic	Semaglutide	67	14
Estradiol	Estradiol	65	29
Famotidine	Famotidine	62	23
Spironolactone	Spironolactone	59	19
Jardiance	Empagliflozin	57	17
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Dutasteride	Dutasteride	53	16
Synthroid	Levothyroxine Sodium	52	13
Citalopram Hbr	Citalopram Hydrobromide	51	16
Fluoxetine Hcl	Fluoxetine Hcl	51	12
Buspirone Hcl	Buspirone Hcl	50	13
Duloxetine Hcl	Duloxetine Hcl	50	16
Albuterol Sulfate Hfa	Albuterol Sulfate	49	19
Lorazepam	Lorazepam	49	16
Metformin Hcl	Metformin Hcl	49	17
Prednisone	Prednisone	49	19
Bupropion Xl	Bupropion Hcl	45	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	45	16
Raloxifene Hcl	Raloxifene Hcl	44	14
Xarelto	Rivaroxaban	44	13
Zolpidem Tartrate	Zolpidem Tartrate	44	13
Alprazolam	Alprazolam	43	suppressed
Warfarin Sodium	Warfarin Sodium	43	13
Azithromycin	Azithromycin	42	26
Tramadol Hcl	Tramadol Hcl	42	11
Mirtazapine	Mirtazapine	40	14
Ipratropium Bromide	Ipratropium Bromide	39	suppressed
Potassium Chloride	Potassium Chloride	38	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	11
Tolterodine Tartrate Er	Tolterodine Tartrate	35	13
Glimepiride	Glimepiride	34	12
Propranolol Hcl	Propranolol Hcl	34	suppressed
Mounjaro	Tirzepatide	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	11
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Trospium Chloride	Trospium Chloride	29	12
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Clonazepam	Clonazepam	28	suppressed
Constulose	Lactulose	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Repatha Sureclick	Evolocumab	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	20
Donepezil Hcl	Donepezil Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Pregabalin	Pregabalin	25	11
Allopurinol	Allopurinol	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	12
Nitroglycerin	Nitroglycerin	23	12
Alfuzosin Hcl Er	Alfuzosin Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Rivastigmine	Rivastigmine Tartrate	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Celecoxib	Celecoxib	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	19	suppressed
Febuxostat	Febuxostat	19	suppressed
Finasteride	Finasteride	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Ursodiol	Ursodiol	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Torsemide	Torsemide	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error